PC
PCRX
Market ClosedPacira BioSciences, Inc.
US
825 employees
CEO: Frank D. Lee
Founded: 2011
$25.88
+$0.00(+NaN%)
Market Cap
1.02B
Beta
0.27
52W Range
N/A
Dividend Yield
0.00%
PCRX Price Chart
Historical price performance
Loading MCI price data...
MarketCI Investment Signals
AI-synthesized investment signal for PCRX built from valuation, fundamentals, sentiment, and risk models
Investment Signal
HoldPass %
57.14%
Score
4/7
Fair Value Estimate
Cash flow analysis • Multiple methods
$324.11
AI Price Target
Machine learning • Price prediction
$21.83
Market Sentiment
News & social media analysis
0.00
Value Investor Price
Classic value analysis
$5.12
Financial Health
Bankruptcy risk assessment
1.85
Quality Score
Financial strength rating
8.00
AI Investment Grade
Deep analysis of filings & news
72.00
Key Investment Highlights
Important factors affecting PCRX investment thesis
Due Diligence Analysis
Investment criteria assessment and scoring
Overall Assessment
64.10% Good
Conditions Met
25.00/39.00
Due Diligence Score
64.10%Due Diligence Conditions
Investment analysis conditions and results
Pass | |
Fail | |
Fail | |
Pass | |
Pass | |
Pass |
Showing 1 to 6 of 46 conditions
Latest News
Recent news and updates for PCRX
No recent news available for PCRX
Core Financials
Loading financial data for PCRX...
Explore PCRX
PCRX in the Healthcare
Small Cap